Last reviewed · How we verify

Oxtriphylline — Competitive Intelligence Brief

Oxtriphylline (choline theophyllinate) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: choline theophyllinate. Area: Respiratory.

marketed choline theophyllinate Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1 Respiratory Live · refreshed every 30 min

Target snapshot

Oxtriphylline (choline theophyllinate) — Warner Chilcott Llc.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Oxtriphylline TARGET choline theophyllinate Warner Chilcott Llc marketed choline theophyllinate Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1 1981-01-01
Aminophyllin Aminophyllin University of Padova marketed Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1
Theophyllin Theophyllin University of Bergen marketed Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (choline theophyllinate class)

  1. Warner Chilcott Llc · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Oxtriphylline — Competitive Intelligence Brief. https://druglandscape.com/ci/choline-theophyllinate. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: